Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

NCT07015853 is registered in ClinicalTrials.gov with Stephen Shiao as lead sponsor.

NCT NCT07015853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07015853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
Lead sponsor
Stephen Shiao
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
July 31, 2033
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, tnbc - triple-negative breast cancer